Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 34

1.

Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke.

Roach RE, Helmerhorst FM, Lijfering WM, Stijnen T, Algra A, Dekkers OM.

Cochrane Database Syst Rev. 2015 Aug 27;8:CD011054. doi: 10.1002/14651858.CD011054.pub2. Review.

PMID:
26310586
2.

Current use of oral contraceptives and the risk of first-ever ischemic stroke: A meta-analysis of observational studies.

Xu Z, Li Y, Tang S, Huang X, Chen T.

Thromb Res. 2015 Jul;136(1):52-60. doi: 10.1016/j.thromres.2015.04.021. Epub 2015 Apr 25.

PMID:
25936231
3.

Is postmenopausal hormone replacement therapy suitable after a cardio- or cerebrovascular event?

Windler E, Stute P, Ortmann O, Mueck AO.

Arch Gynecol Obstet. 2015 Jan;291(1):213-7. doi: 10.1007/s00404-014-3485-0. Epub 2014 Oct 17.

PMID:
25322975
4.

Postmenopausal hormone therapy and the risks of coronary heart disease, breast cancer, and stroke.

Prentice RL.

Semin Reprod Med. 2014 Nov;32(6):419-25. doi: 10.1055/s-0034-1384624. Epub 2014 Oct 16. Review.

5.

Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users.

Sidney S, Cheetham TC, Connell FA, Ouellet-Hellstrom R, Graham DJ, Davis D, Sorel M, Quesenberry CP Jr, Cooper WO.

Contraception. 2013 Jan;87(1):93-100. doi: 10.1016/j.contraception.2012.09.015. Epub 2012 Oct 19.

PMID:
23083525
6.

Hormone therapy and the risk of stroke: perspectives 10 years after the Women's Health Initiative trials.

Henderson VW, Lobo RA.

Climacteric. 2012 Jun;15(3):229-34. doi: 10.3109/13697137.2012.656254. Review.

7.

Long-term cerebral cortex protection and behavioral stabilization by gonadal steroid hormones after transient focal hypoxia.

Ulbrich C, Zendedel A, Habib P, Kipp M, Beyer C, Dang J.

J Steroid Biochem Mol Biol. 2012 Aug;131(1-2):10-6. doi: 10.1016/j.jsbmb.2012.01.007. Epub 2012 Feb 2. Review.

PMID:
22326729
8.

Tailoring combination oral contraceptives to the individual woman.

Archer DF, Lasa IL.

J Womens Health (Larchmt). 2011 Jun;20(6):879-91. doi: 10.1089/jwh.2010.2199. Epub 2011 Jun 1. Review.

PMID:
21631372
9.

Hormone therapy administration in postmenopausal women and risk of stroke.

Renoux C, Suissa S.

Womens Health (Lond Engl). 2011 May;7(3):355-61. doi: 10.2217/whe.11.28. Review.

PMID:
21612355
10.

Gonadal steroids prevent cell damage and stimulate behavioral recovery after transient middle cerebral artery occlusion in male and female rats.

Dang J, Mitkari B, Kipp M, Beyer C.

Brain Behav Immun. 2011 May;25(4):715-26. doi: 10.1016/j.bbi.2011.01.013. Epub 2011 Jan 28.

PMID:
21277368
11.

Risk of cardiovascular outcomes in users of estradiol/dydrogesterone or other HRT preparations.

Schneider C, Jick SS, Meier CR.

Climacteric. 2009 Oct;12(5):445-53. doi: 10.1080/13697130902780853.

PMID:
19565370
12.

Are female sex steroids neuroprotective in experimental stroke.

Draca S.

Med Hypotheses. 2009 Dec;73(6):1051-2. doi: 10.1016/j.mehy.2009.04.049. Epub 2009 Jul 9.

PMID:
19545955
13.

Gender and the injured brain.

Vagnerova K, Koerner IP, Hurn PD.

Anesth Analg. 2008 Jul;107(1):201-14. doi: 10.1213/ane.0b013e31817326a5. Review.

14.

Neuroprotection by ovarian hormones in animal models of neurological disease.

Hoffman GE, Merchenthaler I, Zup SL.

Endocrine. 2006 Apr;29(2):217-31. Review.

PMID:
16785598
15.

The neurology of menopause.

Henderson VW.

Neurologist. 2006 May;12(3):149-59. Review.

PMID:
16688016
16.

A comparison of two progestins on myocardial ischemia-reperfusion injury in ovariectomized monkeys receiving estrogen therapy.

Suparto IH, Koudy Williams J, Fox JL, Vinten-Johansen J.

Coron Artery Dis. 2005 Aug;16(5):301-8.

PMID:
16000888
17.

Effects of combined estrogen and progesterone on brain infarction in reproductively senescent female rats.

Toung TJ, Chen TY, Littleton-Kearney MT, Hurn PD, Murphy SJ.

J Cereb Blood Flow Metab. 2004 Oct;24(10):1160-6.

18.

Estrogen and progesterone as neuroprotective agents in the treatment of acute brain injuries.

Stein DG, Hoffman SW.

Pediatr Rehabil. 2003 Jan-Mar;6(1):13-22. Review.

PMID:
12745891
19.

Hormone replacement therapy and associated risk of stroke in postmenopausal women.

Lemaitre RN, Heckbert SR, Psaty BM, Smith NL, Kaplan RC, Longstreth WT Jr.

Arch Intern Med. 2002 Sep 23;162(17):1954-60.

PMID:
12230417
20.

Postmenopausal hormone therapy and the risk of cardiovascular disease: the epidemiologic evidence.

Hu FB, Grodstein F.

Am J Cardiol. 2002 Jul 3;90(1A):26F-29F. Review.

PMID:
12106637
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk